Mr. Hess brings over 15 years of successful leadership experience to his role as Vice President, Market Access and Pricing at SAI MedPartners. Mr. Hess has prior healthcare consultant experience as Senior Principal, Market Access and Commercial at Fishawack Health. His global industry experience includes time at GlaxoSmithKline, Takeda, and most recently, Medicago. Mr. Hess is a graduate of the University of Chicago Booth Management Institute and he completed his MBA at Lake Forest Graduate School of Management with Hotchkiss Scholar Designation.

At Medicago, he was head of North America commercial launch strategy. Mr. Hess developed the go-to-market strategy for the corporate brand and vaccine portfolio (seasonal influenza and COVID-19), which included the early stage commercial development. While at GlaxoSmithKline pharmaceuticals, Mr. Hess was part of the executive leadership team that grew the vaccine business from a portfolio of $250 million to $2.5 billion over his career. His diverse background at GSK included senior-level positions in operations, brand management, pricing strategy, customer engagement, innovation, strategic planning, talent management, and commercial leadership. He was responsible for the hiring and development of more than 200 employees during his time at GSK.

At Takeda pharmaceuticals, Mr. Hess led the M&A business development that integrated new business acquisitions. This included a historic corporate milestone: the first specialty business approved by the Takeda Board of Directors in its 230-year history.